Cleveland BioLabs, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 4.49%58.030.0%$1727.43m
GILDGilead Sciences, Inc. -0.24%75.141.0%$1315.27m
REGNRegeneron Pharmaceuticals, Inc. 1.52%587.002.5%$975.97m
AMGNAmgen, Inc. 0.36%224.941.3%$648.67m
NVAXNovavax, Inc. 0.89%45.24102.0%$584.90m
VRTXVertex Pharmaceuticals, Inc. 0.39%278.461.9%$546.82m
BIIBBiogen, Inc. 0.28%301.341.6%$411.54m
ILMNIllumina, Inc. -2.56%363.473.5%$379.23m
SRNESorrento Therapeutics, Inc. -0.40%4.931.8%$296.49m
ALXNAlexion Pharmaceuticals, Inc. 1.42%116.042.0%$268.81m
SGENSeattle Genetics, Inc. 0.85%152.846.1%$256.67m
AAgilent Technologies, Inc. 0.66%87.261.6%$200.82m
BMRNBioMarin Pharmaceutical, Inc. -0.75%104.814.3%$178.43m
CODXCo-Diagnostics, Inc. -0.30%17.420.0%$170.37m
INCYIncyte Corp. -0.26%100.292.5%$157.09m

Company Profile

Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY.